Fentang Gao
Lanzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
One vs twelve month aspirin after percutaneous coronary intervention for acute myocardial infarction: individual patient-data analysis of TARGET-FIRST and ULTIMATE-DAPT trials.
Journal: European heart journal
Published: July 07, 2026
A dual-view fusion framework using residual gated graph convolution and Mamba for metabolite-disease association prediction with explorations on salivary metabolites.
Journal: Journal of computer-aided molecular design
Published: May 26, 2026
Multi-Head Hypergraph Convolution With Feature Enhancement and Latent Representation Learning for miRNA-Disease Association Prediction.
Journal: IEEE transactions on computational biology and bioinformatics
Published: December 18, 2025
Multimodality imaging in a patient with non-obstructive hypertrophic cardiomyopathy and multivessel coronary artery disease presenting with chest pain: a case report.
Journal: BMC cardiovascular disorders
Published: December 10, 2025
Prediction of circRNA-Disease Associations Based on Graph Isomorphism Networks and Graph Sampling Aggregation.
Journal: IEEE transactions on computational biology and bioinformatics
Published: September 02, 2025
GMC-DMA: GNN-Mamba Co-Contrastive Optimization for Disease-Metabolite Association Prediction.
Journal: Interdisciplinary sciences, computational life sciences
Published: July 09, 2025
Subclavian-to-descending aortic bypass for the treatment of severe late-stage aortic coarctation in a 62-year-old adult: a case report and literature review.
Journal: Frontiers in cardiovascular medicine
Published: May 26, 2025
GADRC: a graph-based approach for drug repositioning with deep residual networks and computational feature-guided undersampling.
Journal: Journal of computer-aided molecular design
Published: April 27, 2025
Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.
Journal: Lancet (London, England)
Published: February 11, 2024
Showing 1-11 of 11
Last Updated: 09/26/2026